Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
INTRODUCTION
Figure 1-1: Map of Indonesia, with Provinces
Figure 1-2: Total Population of Indonesia (2000-2016)
Table 1-1: GDP Growth in Indonesia, 2012-2015
HEALTH STATUS OF INDONESIANS
HEALTHCARE DELIVERY SYSTEM
REGULATION OF IVD DEVICES AND DISTRIBUTION
SCOPE AND METHODOLOGY
SIZE AND GROWTH OF THE IVD MARKET
Figure 1-3: IVD Market in Indonesia, 2017 and 2022
CHAPTER TWO: INDONESIA – A GROWING IVD MARKET
HEALTHCARE EXPENDITURE IN INDONESIA
Figure 2-1: Growth of Health Expenditure per Capita (USD) in Indonesia, 2000-2014
Figure 2-2: Growth of Health Expenditure per Capita in PPP Terms (USD), Indonesia, 2000-2014
HEALTH INDICATORS IN INDONESIA
Figure 2-3: Top 10 Causes of Death in Indonesia
Table 2-1: Life Expectancy and Mortality Rates in Indonesia, 2000-2014 (Life Expectancy, Total; Life Expectancy at Birth, Male; Life Expectancy at Birth, Female; Total Mortality Rate, Adult, Male; Total Mortality Rate, Adult, Female)
PREVALENT INFECTIOUS DISEASES IN INDONESIA
Tuberculosis (TB)
Table 2-2: Assessment of TB Burden in Indonesia, WHO
Table 2-3: Pulmonary Tuberculosis Cases by Province, Indonesia
HIV/AIDS
Table 2-4: The Number of New Cases of HIV and AIDS between 2011 and 2015, Indonesia
Table 2-5: HIV and AIDS Cases in Indonesia, by Province
Malaria
Table 2-6: Incidence of Malaria in Indonesia, by Province
Dengue
Table 2-7: Dengue Hemorrhagic Fever (DHF) Cases in Indonesia, by Province
Filariasis
Table 2-8: Filariasis in Indonesia, 2011-2015
Table 2-9: Filariasis Cases in Indonesia, by Province, 2012-2014
Leptospirosis
Table 2-10: Leptospirosis Cases in Indonesia, by Province, 2011-2015
Typhoid
Table 2-11: Typhoid Prevalence in Indonesia, by Province
Human Papilloma Virus (HPV)
INDONESIAN HEALTHCARE INDUSTRY LANDSCAPE
Figure 2-4: Healthcare Delivery in Indonesia
Healthcare Delivery System
Public Healthcare System: General and Specialty Hospitals
Table 2-12: General and Specialty Hospitals in Indonesia, 2011-2015
Public Healthcare System: Community Healthcare Centers (CHCs/Puskesmas)
Table 2-13: Community Healthcare Centers in Indonesia, 2011-2015
Table 2- 14: Distribution of Puskesmas (CHCs) in Indonesia across 34 Provinces
Hospital Classification in Indonesia
Table 2-15: Selected General and Specialty Hospitals in Indonesia
Private Healthcare System
Table 2-16: Selected Leading Private Hospitals in Indonesia, by Province
Private Labs in Indonesia
Table 2-17: Selected Private Laboratories in Indonesia
FINANCIAL ASPECTS OF THE HEALTHCARE INDUSTRY IN INDONESIA
Table 2-18: Indonesia Healthcare Spending Compared to Southeast Asia Neighbors (New Zealand, Japan, Australia, South Korea,
Vietnam, China, Singapore, India, Malaysia, Thailand)
Table 2-19: Indonesia Healthcare Expenditure, 2000-2014 (Total Health Expenditure as % of GDP, Public Health Expenditure, Private
Health Expenditure)
Implementation of UHC
Private Health Insurance
E-CATALOGUE PRICING SYSTEM
KEY MARKET DRIVERS OF THE INDONESIAN HEALTHCARE MARKET
KEY CHALLENGES IN THE INDONESIAN HEALTHCARE MARKET
Uncertainty among Private Insurers
Rigid Reference Model Hampering Healthcare Accessibility
Limited Access to Quality Healthcare Facilities
Gap between Supply and Demand of Medical Professionals
Impact of the E-Catalogue Pricing System
Impact of Government’s Policies on Foreign Direct Investments (FDI)
Logistics Challenges
IVD PRODUCT REGULATION IN INDONESIA
Table 2-20: Classification of Medical Devices
IMPORTANT FACTORS TO CONSIDER WHILE CHOOSING AN IVD DISTRIBUTOR IN INDONESIA
Trade-Off between Small and Big Distributors
Table 2-21: Selected Foreign Companies and Their Key Distributors in Indonesia
PROCESSES FOR DISTRIBUTION LICENSE, COMPANY AND PRODUCT REGISTRATIONS
Company/Product Registration
Table 2-22: Licenses Required for IVD Distribution in Indonesia
REGULATORY TRENDS AND INSIGHTS RELEVANT FOR THE IVD SECTOR
Market Transition to E-Catalogue and Related Regulations
REGULATIONS FOR FOREIGN DIRECT INVESTMENTS (FDI)
Table 2-23: Indonesia Investment Coordinating Board (BKPM) Offices
SETTING UP A COMPANY IN INDONESIA
Table 2-24: Options for a Foreign IVD Company to Enter the Indonesian Market
Assessing Option 1: Opening an Affiliated Branch Office in Indonesia
Assessing Option 2: Select a Suitable Exclusive Distributor
Assessing Option 3: Set up OEM Operations; Invest in Local Manufacturing within 3 years
BUSINESS STRATEGIES ADOPTED BY MULTINATIONAL COMPANIES (MNCS): CASE STUDIES
Roche
bioMerieux
Thermo Fisher Scientific
Conclusion
CHAPTER THREE: IVD MARKET ANALYSIS
MICROBIOLOGY
LFIA Tests (Rapid Tests) for Infectious Diseases
Table 3-1: Sales of Rapid Tests for Infectious Diseases by Category, Indonesia, 2017-2022 (HIV; STDs; Hepatitis [HBV, HCV, etc.]; Other [includes Dengue, Malaria, Typhoid, RSV, Filariasis, etc.]; Rapid Tests-Infectious Diseases, Total)
Table 3-2: Popular Rapid Test Brands and Their Distributors in Indonesia
Lab-based Immunoassays for Infectious Diseases
Table 3-3: STD Test Costs at Selected Clinics and Hospitals in Indonesia
Table 3-4: Major Diseases and Demand for Lab-based Immunoassay Diagnostics in Indonesia, 2017-2022 (HIV; STDs; Hepatitis [HBV, HCV, etc.]; Other [includes Dengue, Malaria, Typhoid, RSV, Filariasis, etc.]; Lab-based Immunoassays – Infectious Diseases, Total)
ID/AST
Molecular Diagnostics
Table 3-5: Microbiology Sales in Indonesia, 2017-2022 (Rapid Tests-Infectious Diseases; Lab-based Immunoassays – Infectious Diseases; Molecular Diagnostics – Microbiology; Other [includes supplies, reagents, etc.]; Microbiology, Total)
HEMATOLOGY
Table 3-6: List of Major Players in the Indonesian Hematology Market
Table 3-7: Hematology Sales by Category, Indonesia, 2017-2022 (Hematology Systems; Hematology POC; Other [Digital imaging, analysis software, etc.]; Hematology, Total)
CLINICAL CHEMISTRY
Table 3-8: List of Major Players in the Indonesian Clinical Chemistry Market
Table 3-9: Clinical Chemistry Analyzer Sales by Category, Indonesia, 2017-2022 (General Chemistry; Blood Gas Analyzers; Critical Care POC; Clinical Chemistry, Total)
POINT-OF-CARE TESTS
POC – OTC/ Self-Testing
POC – Professional-Testing
POC Hand-Held Devices
POC Bench-Top Analyzers
Table 3-10: POC Sales by Category, Indonesia, 2017-2022 (POC-Diabetes; POC-OTC/Self-Testing, Other; POC-OTC/Self Testing, Total;
Cardiac Markers; DOA/Toxicology; Other; POC-Professional, Total; POC, Total)
IMMUNOASSAYS
Point-of-Care (POC) Immunoassays
Immunoassays for Non-Infectious Diseases
Table 3-11: Immunoassay (Non-Infectious) Sales by Category, Indonesia, 2017-2022 (Diabetes; Cardiac markers; Other [Cancer
Markers, DOA tests; cholesterol, RIAs for thyroid, hormones, endocrine markers, etc.]; Total, Lab-based Immunoassays – Non-
Infectious; DOA testing – rapid tests; Cancer markers – Rapid tests; Cardiac markers – Rapid tests; Others [Pregnancy, Cancer markers,
etc.]; Total, POC – Immunoassays – Non-Infectious; Total – Immunoassays – Non-Infectious)
BLOOD TESTING AND TYPING
Table 3-12: Distribution of Blood Centers in Indonesia, by Province
Non-Standardized Evaluation Protocol
Table 3-13: Blood Testing and Typing Sales by Category (ABO Grouping, Immunoassays [ELISA and Rapid Tests], NAT), Indonesia,
2017-2022
URINALYSIS
Table 3-14: List of Major Players in the Indonesian Urinalysis Market
COAGULATION
Table 3-15: List of Major Players in the Indonesian Coagulation Market
Table 3-16: Hemostasis Sales by Category (Lab-based Coagulation Tests, POC Coagulation Tests), Indonesia, 2017-2022
HISTOLOGY
Table 3-17: List of Major Players in the Indonesian Histology Market
Table 3-18: Histology Sales by Category (Traditional Non-Pap Stains, Pap Tests, HPV, Other [includes ISH, IHC, Digital Imaging, CTC,
and Flow Cytometry]), Indonesia, 2017-2022
TOTAL IVD MARKETS IN INDONESIA
Table 3-19: Total IVD Market in Indonesia by Segment (Microbiology, Hematology, Clinical Chemistry, POC, Immunoassays – Non-
Infectious Diseases, Blood Testing and Typing, Urinalysis, Coagulation, Histology, Others [includes Molecular Diagnostics (Non-
Infectious), Supplies, Reagents, IT, Imaging, Automation, etc.]), 2017-2022
CHAPTER FOUR: IVD COMPANIES, PRIVATE LABS AND DISTRIBUTOR PROFILES
IVD COMPANY PROFILES
Abbott Laboratories
Alere
Arkray Healthcare
Beckman Coulter
Becton, Dickinson and Company (BD)
bioMerieux
Bio-Rad
Cellavision
Cepheid
Critical Diagnostics
DiaSorin S.p.A.
EKF Diagnostics
ERBA Diagnostics
HemoCue AB
Hologic, Inc.
Horiba, Ltd.
Instrumentation Laboratory Company
Luminex Corporation
Mindray Medical International Limited
Nihon Kohden Corporation
Ortho Clinical Diagnostics
Qiagen N.V.
Radiometer Medical ApS
Randox Laboratories
Roche Diagnostics
Siemens Healthineers
Sysmex Corporation
Thermo Fisher Scientific
Tosoh Corporation
Trinity Biotech
LEADING PRIVATE LABS IN INDONESIA
Laboratorium Klinik Utama Bio Medika
PT Cito Putra Utama
PT Kimia Farma Diagnostika
Laboratorium Klinik Pramita
PT Prodia Widyahusada Tbk
PROFILES OF SELECTED IVD DISTRIBUTORS IN INDONESIA
Table 4-1: Profiles of Selected IVD Distributors in Indonesia
